Skip to content
MarketScale
‹ Back to IndustriesHealthcare

Reichert Brings Cutting-Edge Eye Care Tech to Vision Expo East 2025

Reichert Technologies showcased next-generation ophthalmic diagnostic tools at Vision Expo East 2025, highlighting innovations designed to help eye care practitioners more accurately detect and treat vision disorders. The company demonstrated advanced instruments aimed at improving clinical workflows and patient outcomes. Their presence at the expo underscored growing momentum in diagnostic technology within the eye care industry.

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Promoted content from Reichert on MarketScale.

By Healthcare ·
Share

Key takeaways

01

Reichert Technologies presented cutting-edge ophthalmic diagnostic equipment at Vision Expo East 2025.

02

The showcased tools are designed to enhance early detection and treatment of vision disorders.

03

The event highlighted broader industry trends toward next-generation, technology-driven eye care solutions.

Get featured

Want to get featured in MarketScale Healthcare?

Create a free MarketScale workspace and get your company's expertise featured across our Healthcare coverage. No credit card, no demo required.

Request an invite

As eye care rapidly evolves,

Vision Expo East 2025

is the place to see where innovation meets clinical excellence — and

Reichert

is leading the charge. At booth F2201, practitioners can experience hands-on demos of

Reichert's

latest breakthroughs in tonometry, digital refraction, and dry eye diagnostics. Of particular note is the new

Tono-Vera® Tonometer

, which simplifies intraocular pressure readings with its patented

ActiView™ Positioning System

.

Reichert is also showcasing its premium Phoroptor® VRx Digital Refraction System alongside the intuitive SightChek® Digital Phoroptor, offering powerful options for practices of all sizes.

Reichert

is also showcasing its premium

Phoroptor® VRx Digital Refraction System

alongside the intuitive

SightChek® Digital Phoroptor

, offering powerful options for practices of all sizes. With dry eye disease on the rise, their suite of evaluation and therapy devices helps practices meet growing demand. Visitors can also explore the

Ocular Response Analyzer® G3

, a game-changer in glaucoma management with its unique Corneal Hysteresis and IOPcc metrics. Plus, for those who stop by for a demo, there's a chance to win a $1,000 Visa gift card — a rewarding way to explore the future of vision care.

Reichert

Part of this channel

Reichert

News, updates, and expert insights from Reichert.

Visit the channel

Your experts belong here

Every story in MarketScale Healthcare starts with a company putting its clinicians, service-line leaders, and field engineers on the record. Buyers are already reading this topic. The only question is whose experts they find.

Service-line buyers vet vendors quietly, and your clinicians become the proof they find while doing it.

Get your team featuredSee how it works15 minutes, straight to a calendar.

About the author

H
Healthcare

Follow Healthcare Insights

Get new expert content in your inbox.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one Healthcare expert. Your company is full of them.

This article was produced through MarketScale. The same platform turns your clinicians, service-line leaders, and field engineers into the articles, video, and social content Healthcare buyers are searching for. Create a free workspace and see it with your own people. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com’s $220M round makes imaging an API contract for plans and employers

Scan.com closed $220 million in equity and debt. It’s expanding its U.S. imaging network plus API-based scheduling and results delivery. For health plans and employers, imaging is starting to look like a platform procurement and integration decision, not a directory problem.

  • 01If imaging access is bought via an API, the real spec becomes integration depth: two-way scheduling plus results routing into the EMR, according to Business Wire.
  • 02Scan.com’s mix of $90M equity and $130M debt earmarked for M&A and working capital points to a fast-changing imaging provider network, which can help access but demands discipline in contracting and integration testing.
  • 03The same week’s funding news for Elucid ($55M) suggests AI imaging vendors will keep pushing toward FDA-cleared workflow insertions, a different buying path than network-layer platforms.

Sep 4, 2026

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitors pitch audit-ready, AI-ready device platforms

MD&M West 2026 exhibitor messaging suggests compliance testing and AI-ready compute are becoming early decisions, not afterthoughts. Medical Economics described 2026 as a period shaped by rapid technological change, regulatory scrutiny and ongoing economic uncertainty. Medical Design & Outsourcing’s MD&M West 2026 preview points to exhibitors highlighting test equipment, contract manufacturing and other launch support services.

  • 01If a device roadmap includes AI features, the critical path shifts toward data and software evidence that regulators can audit, which means earlier lock-in of compute platforms and test plans, pulling verification and validation into supplier selection.
  • 02MD&M West exhibitor messaging suggests verification and validation capacity is becoming a procurement problem, with rentals and lab-ready gear positioned as a way to avoid booking delays and re-tests, according to Medical Design & Outsourcing.
  • 03With imaging and other new procedural and device concepts moving fast, manufacturing leaders should expect more frequent line-change decisions and component qualification work, as GE HealthCare's photon-counting CT CE mark reported by MedTech Dive and MDDI's New Technologies coverage illustrate.

Sep 3, 2026

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz - Cancer Survivor and Chief Medical Physicist

Dr. Dana Rosencranz brings 23+ years of experience as chief medical physicist at Texas Oncology and personal insight as a breast cancer survivor, enabling her to guide patient support groups and advocate for accessible cancer care. She emphasizes AI's potential in auto-contouring and treatment planning while stressing the need for proper training, validation, and transparency before implementation.

  • 01Over 23 years at Texas Oncology integrating personal cancer survivor experience with clinical expertise to improve patient empathy and support group leadership
  • 02AI in oncology requires human oversight, validation, and transparency; auto-contouring and auto-planning must be combined with staff training and rigorous protocol testing before deployment
  • 03Texas Oncology prioritizes offering state-of-the-art cancer treatments closer to home, including for rural patients, to reduce travel and ensure consistent, personalized care

Sep 3, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub

About the Expert

H
Healthcare

For B2B teams

Your experts could be publishing here

Stories like this one run on content MarketScale captures from real practitioners. See how your team's expertise becomes coverage in Healthcare and beyond.

Book a 15-minute demo

Or call us. No forms required. We pick up. 214-945-2512